Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Stock
Equities
6990
CNE1000062J1
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 416.80 HKD | -2.93% |
|
-10.63% | +6.27% |
| Capitalization | 89.43B 100B 12.84B 10.98B 10.19B 9.56B 17.73B 1,176B 18.99B 117B 46.29B 556B 48.16B 47.17B 2,031B | P/E ratio 2025 * |
-187x | P/E ratio 2026 * | 2,150x |
|---|---|---|---|---|---|
| Enterprise value | 86.5B 96.85B 12.42B 10.62B 9.86B 9.25B 17.15B 1,138B 18.37B 113B 44.77B 538B 46.58B 45.63B 1,964B | EV / Sales 2025 * |
44.3x | EV / Sales 2026 * | 27.7x |
| Free-Float |
59.59% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
More recommendations
More press releases
| 1 day | -2.93% | ||
| 1 week | -10.63% | ||
| Current month | +6.27% | ||
| 1 month | +0.92% | ||
| 3 months | -11.51% | ||
| 6 months | +10.38% | ||
| Current year | +6.27% |
| 1 week | 399.8 |  | 483.8 |
| 1 month | 389.4 | | 495 |
| Current year | 389.4 | | 495 |
| 1 year | 156 | | 581 |
| 3 years | 60.6 | | 581 |
| 5 years | 60.6 | | 581 |
| 10 years | 60.6 | | 581 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jun You Ge
CEO | Chief Executive Officer | 54 | 2022-02-28 |
Ze Jian Zhou
DFI | Director of Finance/CFO | 43 | 2022-08-16 |
Xiao Ping Jin
CTO | Chief Tech/Sci/R&D Officer | 49 | 2021-09-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Ge Xin Liu
CHM | Chairman | 75 | 2022-02-28 |
Jun You Ge
BRD | Director/Board Member | 54 | 2022-02-24 |
Si Chuan Liu
BRD | Director/Board Member | 42 | 2016-11-21 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.93% | -10.63% | +161.97% | - | 12.84B | |
| +0.34% | +1.16% | +11.56% | +92.51% | 49.82B | |
| -0.91% | -4.69% | +77.60% | +1.08% | 42.19B | |
| -4.40% | -4.37% | +103.67% | +648.66% | 33.34B | |
| +11.78% | +8.14% | +0.64% | -17.36% | 29.61B | |
| +1.46% | -2.60% | +114.07% | -45.43% | 20.36B | |
| -0.77% | -7.86% | +35.07% | -23.78% | 20.15B | |
| -1.40% | -8.91% | +91.32% | +122.57% | 13.47B | |
| +4.92% | -4.53% | -23.76% | +283.83% | 12.99B | |
| Average | +0.92% | -3.52% | +63.57% | +132.76% | 26.08B | |
| Weighted average by Cap. | +1.28% | -2.39% | +56.89% | +133.83% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.95B 2.19B 280M 240M 222M 209M 387M 25.68B 415M 2.55B 1.01B 12.14B 1.05B 1.03B 44.33B | 3.11B 3.49B 447M 382M 355M 333M 617M 40.94B 661M 4.07B 1.61B 19.35B 1.68B 1.64B 70.69B |
| Net income | -541M -606M -77.75M -66.47M -61.71M -57.87M -107M -7.12B -115M -708M -280M -3.37B -292M -286M -12.29B | 16.72M 18.73M 2.4M 2.05M 1.91M 1.79M 3.32M 220M 3.55M 21.88M 8.66M 104M 9.01M 8.82M 380M |
| Net Debt | -2.93B -3.28B -421M -360M -334M -313M -581M -38.54B -622M -3.83B -1.52B -18.21B -1.58B -1.55B -66.53B | -3.3B -3.69B -474M -405M -376M -352M -654M -43.37B -700M -4.31B -1.71B -20.5B -1.78B -1.74B -74.88B |
More financial data
* Estimated data
Employees
1,870
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-22 | 416.80 $ | -2.93% | 950,211 |
| 26-01-21 | 429.40 $ | -2.94% | 492,188 |
| 26-01-20 | 442.40 $ | -1.25% | 270,150 |
| 26-01-19 | 448.00 $ | -5.45% | 508,428 |
| 26-01-16 | 473.80 $ | +0.72% | 337,000 |
Delayed Quote Hong Kong S.E., January 22, 2026 at 03:08 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
429.40HKD
Average target price
532.76HKD
Spread / Average Target
+24.07%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 6990 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition